Cargando…
Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127592/ https://www.ncbi.nlm.nih.gov/pubmed/35605430 http://dx.doi.org/10.1016/j.ebiom.2022.104074 |
| _version_ | 1784712387864035328 |
|---|---|
| author | Tan, Wenliang Luo, Xuan Li, Wenda Zhong, Jinyi Cao, Jun Zhu, Sicong Chen, Xianqing Zhou, Rui Shang, Changzhen Chen, Yajin |
| author_facet | Tan, Wenliang Luo, Xuan Li, Wenda Zhong, Jinyi Cao, Jun Zhu, Sicong Chen, Xianqing Zhou, Rui Shang, Changzhen Chen, Yajin |
| author_sort | Tan, Wenliang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9127592 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91275922022-06-07 Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456] Tan, Wenliang Luo, Xuan Li, Wenda Zhong, Jinyi Cao, Jun Zhu, Sicong Chen, Xianqing Zhou, Rui Shang, Changzhen Chen, Yajin eBioMedicine Corrigendum Elsevier 2022-05-20 /pmc/articles/PMC9127592/ /pubmed/35605430 http://dx.doi.org/10.1016/j.ebiom.2022.104074 Text en © 2018 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Corrigendum Tan, Wenliang Luo, Xuan Li, Wenda Zhong, Jinyi Cao, Jun Zhu, Sicong Chen, Xianqing Zhou, Rui Shang, Changzhen Chen, Yajin Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456] |
| title | Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456] |
| title_full | Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456] |
| title_fullStr | Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456] |
| title_full_unstemmed | Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456] |
| title_short | Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456] |
| title_sort | corrigendum to “tnf-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [ebiomedicine 40 (2019) 446–456] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127592/ https://www.ncbi.nlm.nih.gov/pubmed/35605430 http://dx.doi.org/10.1016/j.ebiom.2022.104074 |
| work_keys_str_mv | AT tanwenliang corrigendumtotnfaisapotentialtherapeutictargettoovercomesorafenibresistanceinhepatocellularcarcinomaebiomedicine402019446456 AT luoxuan corrigendumtotnfaisapotentialtherapeutictargettoovercomesorafenibresistanceinhepatocellularcarcinomaebiomedicine402019446456 AT liwenda corrigendumtotnfaisapotentialtherapeutictargettoovercomesorafenibresistanceinhepatocellularcarcinomaebiomedicine402019446456 AT zhongjinyi corrigendumtotnfaisapotentialtherapeutictargettoovercomesorafenibresistanceinhepatocellularcarcinomaebiomedicine402019446456 AT caojun corrigendumtotnfaisapotentialtherapeutictargettoovercomesorafenibresistanceinhepatocellularcarcinomaebiomedicine402019446456 AT zhusicong corrigendumtotnfaisapotentialtherapeutictargettoovercomesorafenibresistanceinhepatocellularcarcinomaebiomedicine402019446456 AT chenxianqing corrigendumtotnfaisapotentialtherapeutictargettoovercomesorafenibresistanceinhepatocellularcarcinomaebiomedicine402019446456 AT zhourui corrigendumtotnfaisapotentialtherapeutictargettoovercomesorafenibresistanceinhepatocellularcarcinomaebiomedicine402019446456 AT shangchangzhen corrigendumtotnfaisapotentialtherapeutictargettoovercomesorafenibresistanceinhepatocellularcarcinomaebiomedicine402019446456 AT chenyajin corrigendumtotnfaisapotentialtherapeutictargettoovercomesorafenibresistanceinhepatocellularcarcinomaebiomedicine402019446456 |